Lupin Spins Out Oncology Programs into Kaveri Therapeutics to Advance Global Clinical Development

  Aims to Raise Capital to Fund Global Clinical Studies for LNP7457 (PRMT5) & LNP8701 (SOS1)  Global pharmaceutical leader Lupin Limited &n...

July 22, 2026 | Wednesday | News
Samsung Biologics Announced CHF 1.46 Billion Tender Offer to Acquire PolyPeptide

  Samsung Biologics to launch an all-cash public tender offer for 100% of PolyPeptide's fully diluted share capital (excluding ...

July 21, 2026 | Tuesday | News
Amneal Received FDA Approval for Additional Iohexol Injection Strengths and Vial Presentations

Approval of iohexol injection 350 mg iodine/mL in 50 mL, 75 mL and 100 mL vials, and 300 mg iodine/mL in 50 mL vial, significantly expands Amneal&rsquo...

July 21, 2026 | Tuesday | News
Arch Biopartners Advanced IL-32 Chronic Kidney Disease Program with U.S. Bioengineering Laboratory

Arch Biopartners Inc. announced that it has engaged a U.S.-based laboratory specializing in bioengineering to accelerate the Company’s pre-IND IL-3...

July 21, 2026 | Tuesday | News
FDA Approved Merck’s Lipfendra as First Oral PCSK9 Inhibitor for High Cholesterol

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type ...

July 21, 2026 | Tuesday | News
Fangzhou Introduced Kyinsu® on Its AI Healthcare Platform Through Novo Nordisk Collaboration

Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, annou...

July 21, 2026 | Tuesday | News
Aptar Pharma Introduces Collaborative Framework for Injectable Drug Delivery Systems

Aptar Pharma, a global leader in drug delivery, dosing, protection technologies and services, announced a collaborative system-level framework for inject...

July 20, 2026 | Monday | News
Bayer and Henry Ford Health Partner to Expand Patient Access to Clinical Trials

Bayer, a global life sciences company, and Henry Ford Health announced a strategic partnership to expand clinical trial opportunities for patients. The w...

July 20, 2026 | Monday | News
Crown Bioscience Joins C-Path Coalition to Advance Human-Relevant Drug Development Methods

-Crown Bioscience is a global contract research organization (CRO) specializing in oncology drug discovery and development, today announced it has joined...

July 20, 2026 | Monday | News
Parse Biosciences Expands Single Cell Sequencing Access in Asia-Pacific Through Garvan Institute Partnership

Parse Biosciences, a QIAGEN company, and the leader in scalable and accessible single cell sequencing, today announced that the Genomics Platform Core Fa...

July 20, 2026 | Monday | News
Ascletis Selected Oral ASC30 and ASC48 Combination for Obesity Clinical Development

ASC48 is a potentially first-in-class oral small molecule GIPR agonist. - ASC48 demonstrated an EC50 of 1 pM in the hGIPR cAMP activation assay, exhibit...

July 17, 2026 | Friday | News
CellCarta Launched Global Digital Pathology and AI Consortium for Precision Medicine

Consortium initially brings together Lunit, Mindpeak, Imagene AI, Dipath AI, Nucleai, Tivenix and Indica Labs to give biopharma sponsors a single CRO-led...

July 17, 2026 | Friday | News
Primrose Bio Secured $2 Million NIH Grant to Advance DNA- and RNA-Based Medicine Research

$2 million grant builds on research to develop sequence elements that improve DNA- and RNA-based medicine efficacy Primrose Bio, Inc., a company with pr...

July 17, 2026 | Friday | News
CPC Biotech Introduced RevolveSD™ Series for Faster Sterile Single-Use Bioprocess Disconnections

CPC Biotech, part of PSG and Dover (NYSE: DOV) and a leading manufacturer of connectors, pumps, and flow sensors used in biopharmaceu...

July 17, 2026 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close